Congress 2014 has ended
Friday, May 2 • 12:45pm - 1:45pm
A Targeted Therapy for First-Line Treatment of Chronic Lymphocytic Leukemia

Sign up or log in to save this to your schedule and see who's attending!

This theater presentation will review the efficacy and safety of GAZYVA in combination with chlorambucil as shown in CLL11; explore the proposed mechanism of action of GAZYVA; and review the dosing and administration of GAZYVA in previously untreated patients with chronic lymphocytic leukemia. 

A Genentech promotional activity in conjunction with ONS:Edge, Inc., a subsidiary of ONS.

This event qualifies for the ONS:Edge Unlock the Levels of Learning contest. Seating is on a first-come, first-served basis. Please plan to arrive early to have the best chance at securing your seat. 

Friday May 2, 2014 12:45pm - 1:45pm
Theater 2, Hall B Anaheim Convention Center, 800 W. Katella Ave, Anaheim, CA 92802
  • CNE Status No CNE
  • Contact Hours of CNE: N/A

Attendees (0)